Literature DB >> 12973858

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.

Pierre Fumoleau, Joanne L Blum, Peter Reichardt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12973858     DOI： 10.1002/cncr.11577

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.

Authors:  Antonio Antón; Agustí Barnadas; Jesús Florián; Nuria Ribelles; María Lomas; Juan Lao; Ana González-Quintás; Mireia Margelí; Ana Belén Paules; Javier Gayo; Manuel Ramos
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

2.  A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines.

Authors:  George Orphanos; Athanasios Alexopoulos; Savvoula Malliou; George Ioannidis; Alexandros Ardavanis; Constantinos Kandylis; John Stavrakakis; Gerassimos Rigatos
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.